Roche names head of small molecules research

Wednesday, September 14, 2011 11:44 AM

Roche has named Rainer Metternich, PhD, head of small molecules research (SMR), effective immediately. He takes over from Klaus Strein, who will retire from Roche.

As head of SMR, Rainer will lead some 800 scientists across Europe and the US who work in medicinal chemistry, discovery technologies, process research and formulation. He will oversee the development of SMR's mid- and long-term vision and strategy and guide the group as it applies novel technologies to develop world-class compounds.

Rainer brings more than two decades of experience in the pharma industry. Most recently, Rainer served as chief scientific officer and chief business officer with Caprotec, a biotechnology company in Berlin.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs